Michael McCullar is the founder of OnQuality Pharmaceuticals. OnQuality Pharmaceuticals has raised $35M in total funding. Latest round: Series A.
Michael McCullar is the CEO of OnQuality Pharmaceuticals. The company recently raised $20 million in Series A+ funding to support its Phase II oncodermatology trial. OnQuality Pharmaceuticals develops targeted supportive care agents that address specific side effects of cancer treatments, with their lead candidate, OQL011, being a topical ointment for Hand Foot Skin Reaction (HFSR).
Full founder directory · Investor directory · Company funding database · Fundraising library